Reports: Hamlet Pharma AB (publ): Q3 Interim Report January 2023 – March 2023

Market Notices: Market Notice 111/23 – Last day of trading in Hamlet Pharma AB´s subscription option HAMLET TO 4 B

Press release from Companies: Introducing Hamlet BioPharma to investors

Press release from Companies: Kommuniké Från Extra Bolagsstämman i Hamlet Pharma AB

Press release from Companies: Kommuniké Från Extra Bolagsstämman i Hamlet Pharma AB

Press release from Companies: Teckningskurs för utnyttjande av teckningsoptioner serie TO 4 B i Hamlet Pharma AB (Publ) har fastställts till 2,32 SEK per aktie

Press release from Companies: Hamlet Pharma achieves full funding from the European Commission

Press release from Companies: Hamlet Pharma achieves full funding from the European Commission

Press release from Companies: Notice of extraordinary general meeting in Hamlet Pharma AB (publ)

Press release from Companies: Notice of extraordinary general meeting in Hamlet Pharma AB (publ)

Press release from Companies: Kallelse till extra bolagsstämma i Hamlet Pharma AB (publ)

Market Notices: Market notice 83/23– Hamlet Pharma AB’s shares and subscription options HAMLET B and HAMLET TO 4 B is moved to the Observation List